Age and frailty in COVID-19 vaccine development.
作者信息
Andrew Melissa K, McElhaney Janet E
机构信息
Department of Medicine (Geriatrics) and Canadian Center for Vaccinology, Dalhousie University, Halifax, B3H 2E1, NS, Canada.
Health Sciences North Research Institute, Sudbury, ON, Canada.
出版信息
Lancet. 2021 Dec 19;396(10267):1942-1944. doi: 10.1016/S0140-6736(20)32481-8. Epub 2020 Nov 19.
Abstract
摘要
相似文献
1
Age and frailty in COVID-19 vaccine development.
Lancet. 2021 Dec 19;396(10267):1942-1944. doi: 10.1016/S0140-6736(20)32481-8. Epub 2020 Nov 19.
2
Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study.
BMC Geriatr. 2020 Oct 16;20(1):409. doi: 10.1186/s12877-020-01803-5.
3
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study.
Lancet Public Health. 2020 Aug;5(8):e444-e451. doi: 10.1016/S2468-2667(20)30146-8. Epub 2020 Jun 30.
4
Association of frailty with mortality in older inpatients with Covid-19: a cohort study.
Age Ageing. 2020 Oct 23;49(6):915-922. doi: 10.1093/ageing/afaa184.
5
COVID-19, frailty and long-term care: Implications for policy and practice.
J Infect Dev Ctries. 2020 May 31;14(5):428-432. doi: 10.3855/jidc.13003.
6
Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
Vaccine. 2016 Apr 4;34(15):1806-9. doi: 10.1016/j.vaccine.2016.02.037. Epub 2016 Feb 28.
7
The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age.
Hum Vaccin Immunother. 2018 Feb 1;14(2):361-367. doi: 10.1080/21645515.2017.1405883. Epub 2017 Dec 20.
8
[Assessing frailty in care practices : quick reminders in the light of the Covid-19 pandemic].
Rev Med Suisse. 2020 Jul 1;16(699):1316-1318.
9
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection.
J Investig Med. 2020 Aug;68(6):1199-1202. doi: 10.1136/jim-2020-001410. Epub 2020 Jul 7.
10
Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic.
Swiss Med Wkly. 2020 Apr 30;150:w20269. doi: 10.4414/smw.2020.20269. eCollection 2020 Apr 20.
引用本文的文献
1
Population-Based Analysis of Vaccination Status and Post-Vaccination Adverse Events in Adults Aged 55 and Older.
J Clin Med. 2025 Jun 17;14(12):4297. doi: 10.3390/jcm14124297.
2
Neutralizing antibody responses to three XBB protein vaccines in older adults.
Signal Transduct Target Ther. 2025 Feb 3;10(1):48. doi: 10.1038/s41392-025-02132-y.
3
Humoral immune response to an mRNA-1273 booster after chAdOx1-nCoV-19-priming among patients undergoing hemodialysis.
Tzu Chi Med J. 2023 Oct 6;35(4):343-347. doi: 10.4103/tcmj.tcmj_107_23. eCollection 2023 Oct-Dec.
4
SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus.
Endocrine. 2023 Nov;82(2):226-236. doi: 10.1007/s12020-023-03471-y. Epub 2023 Aug 16.
5
The degree of frailty as a translational measure of health in aging.
Nat Aging. 2021 Aug;1(8):651-665. doi: 10.1038/s43587-021-00099-3. Epub 2021 Aug 12.
6
Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: A real-life study.
Rev Esp Geriatr Gerontol. 2023 May-Jun;58(3):125-133. doi: 10.1016/j.regg.2023.02.009. Epub 2023 Mar 6.
7
Sialic acid-mediated photochemotherapy enhances infiltration of CD8 T cells from tumor-draining lymph nodes into tumors of immunosenescent mice.
Acta Pharm Sin B. 2023 Jan;13(1):425-439. doi: 10.1016/j.apsb.2022.06.005. Epub 2022 Jun 11.
8
Frailty Reduces Vaccine Effectiveness Against SARS-CoV-2 Infection: A Test-Negative Case Control Study Using National VA Data.
J Nutr Health Aging. 2023;27(2):81-88. doi: 10.1007/s12603-023-1885-1.
9
Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults.
Immun Ageing. 2023 Jan 17;20(1):4. doi: 10.1186/s12979-023-00327-x.
10
Age discrimination, the right to life, and COVID-19 vaccination in countries with limited resources.
J Soc Issues. 2022 Sep 30. doi: 10.1111/josi.12561.
本文引用的文献
1
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
2
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
J Am Geriatr Soc. 2021 Mar;69(3):744-752. doi: 10.1111/jgs.16917. Epub 2020 Nov 16.
3
COVID-19, frailty and long-term care: Implications for policy and practice.
J Infect Dev Ctries. 2020 May 31;14(5):428-432. doi: 10.3855/jidc.13003.
4
The immune response to influenza in older humans: beyond immune senescence.
Immun Ageing. 2020 May 7;17:10. doi: 10.1186/s12979-020-00181-1. eCollection 2020.
5
Influenza Vaccination: Accelerating the Process for New Vaccine Development in Older Adults.
Interdiscip Top Gerontol Geriatr. 2020;43:98-112. doi: 10.1159/000504478. Epub 2020 Apr 9.
6
Evaluation of two frailty indices, with practical application in a vaccine clinical trial.
Hum Vaccin Immunother. 2019;15(12):2960-2968. doi: 10.1080/21645515.2019.1622974. Epub 2019 Jun 21.
7
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.
8
Frailty, Inflammation and Immunosenescence.
Interdiscip Top Gerontol Geriatr. 2015;41:26-40. doi: 10.1159/000381134. Epub 2015 Jul 17.
9
Frailty in elderly people.
Lancet. 2013 Mar 2;381(9868):752-62. doi: 10.1016/S0140-6736(12)62167-9. Epub 2013 Feb 8.
10
Immunological responses to pneumococcal vaccine in frail older people.
Vaccine. 2009 Mar 4;27(10):1628-36. doi: 10.1016/j.vaccine.2008.11.098. Epub 2008 Dec 17.
Zotero 插件